Table 1

Predicted and observed fibrinogen chain masses in 21 healthy subjects

Fibrinogen chain/phosphorylation state*Sialylation stateCommon polymorphismsPredicted mass, DaObserved mass, mean (SD)
Aα     
  312A 66 102 66 101 (4) 
  312T 66 132 66 134 (4) 
    1  312A 66 182 66 180 (5) 
    1  312T 66 212 66 214 (4) 
    2  312A 66 262 66 259 (4) 
    2  312T 66 292 66 293 (4) 
Bβ     
 448K 54 185 54 182 (2) 
 448R 54 213 54 213 (3) 
 448K 54 476 54 473 (2) 
 448R 54 504 54 504 (3) 
γ     
  48 368 48 381 (3) 
  48 659 48 672 (3) 
Fibrinogen chain/phosphorylation state*Sialylation stateCommon polymorphismsPredicted mass, DaObserved mass, mean (SD)
Aα     
  312A 66 102 66 101 (4) 
  312T 66 132 66 134 (4) 
    1  312A 66 182 66 180 (5) 
    1  312T 66 212 66 214 (4) 
    2  312A 66 262 66 259 (4) 
    2  312T 66 292 66 293 (4) 
Bβ     
 448K 54 185 54 182 (2) 
 448R 54 213 54 213 (3) 
 448K 54 476 54 473 (2) 
 448R 54 504 54 504 (3) 
γ     
  48 368 48 381 (3) 
  48 659 48 672 (3) 
*

Denotes the number of phosphate groups (80 Da each) attached to the chain.

Denotes the number of sialic acid groups (291 Da each) attached to the chain.

Predicted masses of the fibrinogen chains16  were used to identify predominant LC-MS peaks that would be expected in a normal population. These include nonphosphorylation, monophosphorylation, and diphosphorylation of the Aα chain; monosialylation and disialylation of the Bβ and γ chains; and the common polymorphisms Aα T312A and Bβ R448K, which have allele frequencies of 24% and 15%, respectively, in healthy subjects.

or Create an Account

Close Modal
Close Modal